Arovella Therapeutics Ltd
ASX:ALA

Watchlist Manager
Arovella Therapeutics Ltd Logo
Arovella Therapeutics Ltd
ASX:ALA
Watchlist
Price: 0.18 AUD -5.26% Market Closed
Market Cap: 189.3m AUD
Have any thoughts about
Arovella Therapeutics Ltd?
Write Note

Arovella Therapeutics Ltd
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Arovella Therapeutics Ltd
Interest Income Expense Peer Comparison

Comparables:
MYX
NEU
BOT
PBP
VLS

Competitive Interest Income Expense Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Arovella Therapeutics Ltd
ASX:ALA
Interest Income Expense
-AU$8.6k
CAGR 3-Years
36%
CAGR 5-Years
41%
CAGR 10-Years
N/A
Mayne Pharma Group Ltd
ASX:MYX
Interest Income Expense
AU$679k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Neuren Pharmaceuticals Ltd
ASX:NEU
Interest Income Expense
AU$1.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Botanix Pharmaceuticals Ltd
ASX:BOT
Interest Income Expense
AU$46.6k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Probiotec Ltd
ASX:PBP
Interest Income Expense
-AU$6m
CAGR 3-Years
-40%
CAGR 5-Years
-37%
CAGR 10-Years
-15%
Vita Life Sciences Ltd
ASX:VLS
Interest Income Expense
AU$754k
CAGR 3-Years
166%
CAGR 5-Years
19%
CAGR 10-Years
54%

See Also

What is Arovella Therapeutics Ltd's Interest Income Expense?
Interest Income Expense
-8.6k AUD

Based on the financial report for Jun 30, 2024, Arovella Therapeutics Ltd's Interest Income Expense amounts to -8.6k AUD.

What is Arovella Therapeutics Ltd's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
41%

Over the last year, the Interest Income Expense growth was 58%. The average annual Interest Income Expense growth rates for Arovella Therapeutics Ltd have been 36% over the past three years , 41% over the past five years .

Back to Top